Key result
Scalable feeder-free method differentiates human iPSCs into endocardial cells forming valvular interstitial and endothelial cells.
Why the study?
Advancements in valve biology and therapeutics have been hindered by the lack of accessibility to human valve cells.
A novel feeder-free method successfully differentiates human iPSCs into endocardial and cardiac valve cells, providing a scalable model for studying valve biology and disease.
Facilitates in vitro valvular disease modeling; leaves open clinical translation of iPSC-derived endocardial cells.
Valvular heart disease presents a significant health burden, yet advancements in valve biology and therapeutics have been hindered by the lack of accessibility to human valve cells. In this study, we have developed a scalable and feeder-free method to differentiate human induced pluripotent stem cells (iPSCs) into endocardial cells, which are transcriptionally and phenotypically distinct from vascular endothelial cells. These endocardial cells can be challenged to undergo endothelial-to-mesenchymal transition (EndMT), after which two distinct populations emerge-one population undergoes EndMT to become valvular interstitial cells (VICs), while the other population reinforces their endothelial identity to become valvular endothelial cells (VECs). We then characterized these populations through bulk RNA-seq transcriptome analyses and compared our VIC and VEC populations to pseudobulk data generated from normal valve tissue of a 15-week-old human fetus. By increasing the accessibility to these cell populations, we aim to accelerate discoveries for cardiac valve biology and disease.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied Valvular heart disease. Feeder-free differentiation of human induced pluripotent stem cells (iPSCs) was evaluated on Generation of endocardial cells and subsequent endothelial-to-mesenchymal transition (EndMT). A scalable, feeder-free method successfully differentiated human induced pluripotent stem cells into endocardial cells capable of forming valvular interstitial and endothelial cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: